Loading
Latest filing published 10 Feb 2026 for SeaStar Medical Holding Corp.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin Chung is a declared insider of SeaStar Medical Holding Corp, with filings sourced from SEC (Form 4). Over a trading history stretching from 5 April 2022 to 6 February 2026, the count stands at 18 filings.
No open-market sale appears; the market trades are 10 purchases worth €41k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 7 share grants and 1 option exercise.
A typical purchase (the median) is worth €4,347. Clusters matter here: 4 out of 9 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 10 February 2026, reports a share grant in SeaStar Medical Holding Corp. The latest purchase dates back some time: it was published 428 days ago, on 25 August 2025. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations